BIONXT SOLUTIONS INC. (BXT) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.080x

Based on the latest financial reports, BIONXT SOLUTIONS INC. (BXT) has a cash flow conversion efficiency ratio of 0.080x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-588.29K ≈ $-687.77K USD) by net assets (€-7.32 Million ≈ $-8.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of BIONXT SOLUTIONS INC. for the company's overall valuation and market capitalisation.

BIONXT SOLUTIONS INC. - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how BIONXT SOLUTIONS INC.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

BIONXT SOLUTIONS INC. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BIONXT SOLUTIONS INC. ranked by their cash flow conversion efficiency. See BXT operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Ram Technology Co. Ltd KQ:171010	-0.015x
Optimi Health Corp. Common Shares NASDAQ:OPTH	-0.162x
Kyobo 3 SPAC KQ:208710	0.033x
Ntaw Holdings Ltd AU:NTD	0.021x
Hunyvers SA PA:ALHUN	0.032x
Aetherium Acquisition Corp NASDAQ:GMFI	N/A
Eqva ASA OL:EQVA	0.112x
Ropharma Bras RO:RPH	0.057x

Annual Cash Flow Conversion Efficiency for BIONXT SOLUTIONS INC. (2021–2025)

The table below shows the annual cash flow conversion efficiency of BIONXT SOLUTIONS INC. from 2021 to 2025. View BIONXT SOLUTIONS INC. stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€-9.37 Million ≈ $-10.95 Million	€-5.20 Million ≈ $-6.07 Million	0.555x	+43.74%
2024-12-31	€-7.86 Million ≈ $-9.19 Million	€-3.03 Million ≈ $-3.55 Million	0.386x	-60.55%
2023-12-31	€-5.28 Million ≈ $-6.18 Million	€-5.17 Million ≈ $-6.04 Million	0.978x	-35.17%
2022-12-31	€-4.13 Million ≈ $-4.83 Million	€-6.23 Million ≈ $-7.28 Million	1.509x	+120.72%
2021-12-31	€1.67 Million ≈ $1.95 Million	€-12.16 Million ≈ $-14.21 Million	-7.284x	--

About BIONXT SOLUTIONS INC.

F:BXT Germany Drug Manufacturers - Specialty & Generic

Market Cap

$31.34 Million

€26.80 Million EUR

Market Cap Rank

#24492 Global

#2109 in Germany

Share Price

€0.20

Change (1 day)

+2.07%

52-Week Range

€0.17 - €0.57

All Time High

€2.28